Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 5/20 | 0.44 |
| ▸ | ACHE | P22303 | 6/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7542609 | 1.00 | EPHX2 (0.44) | EPHX2ACHECYP2C19ALDH1A1LMNA | |
| SCHEMBL7542583 | 1.00 | EPHX2 (0.44) | EPHX2ACHECYP2C19ALDH1A1LMNA | |
| SCHEMBL7544974 | 1.00 | EPHX2 (0.44) | EPHX2ACHECYP2C19ALDH1A1LMNA | |
| SCHEMBL7550809 | 1.00 | EPHX2 (0.44) | EPHX2ACHECYP2C19ALDH1A1LMNA | |
| SCHEMBL7547884 | 1.00 | EPHX2 (0.44) | EPHX2ACHECYP2C19ALDH1A1LMNA | |
| SCHEMBL7550550 | 0.98 | EPHX2 (0.42) | EPHX2ACHEALDH1A1LMNAPOLB | |
| SCHEMBL7550215 | 0.94 | EPHX2 (0.44) | EPHX2ACHEALDH1A1TSHREPHX1 | |
| SCHEMBL7549085 | 0.94 | EPHX2 (0.44) | EPHX2ACHEALDH1A1TSHREPHX1 | |
| SCHEMBL7550559 | 0.94 | EPHX2 (0.44) | EPHX2ACHEALDH1A1TSHREPHX1 | |
| SCHEMBL7545856 | 0.94 | EPHX2 (0.44) | EPHX2ACHEALDH1A1TSHREPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | claimed |
| EP-0824316-A4 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 2001-01-17 | — | — | EP | claimed |
| US-5767152-A | USING A CYANOCARBOXYLIC ACID | S.N. BIOTECH, INC. | 1998-06-16 | — | — | US | claimed |
| EP-0824316-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | Nielsen, Thor, B. (US) | 1998-02-25 | — | — | EP | claimed |
| WO-1996034526-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 1996-11-07 | — | — | WO | claimed |
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | disclosed |
| EP-0824316-A4 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 2001-01-17 | — | — | EP | disclosed |
| US-5767152-A | USING A CYANOCARBOXYLIC ACID | S.N. BIOTECH, INC. | 1998-06-16 | — | — | US | disclosed |
| EP-0824316-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | Nielsen, Thor, B. (US) | 1998-02-25 | — | — | EP | disclosed |
| WO-1996034526-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 1996-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | AREG, NGF, HDGF | EPHX2 1678/4885ACHE 2341/4885CYP2C19 3778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.